Bionano Genomics (BNGO) Gains from Investment Securities (2017 - 2024)
Bionano Genomics (BNGO) reported Gains from Investment Securities of -$5.8 million for Q3 2024, down 1962.58% on a YoY basis from $310000.0 in Q4 2023, and down 29.0% sequentially from -$4.5 million in Q2 2024.
Bionano Genomics (BNGO) Gains from Investment Securities (2017 - 2024) Analysis & Trends
Bionano Genomics (BNGO) has 6 years of Gains from Investment Securities data on file, last reported at -$5.8 million in Q3 2024.
- For the quarter ending Q3 2024, Gains from Investment Securities fell 1962.58% year-over-year to -$5.8 million; the trailing twelve-month figure through Jun 2025 stood at -$5.8 million (up 34.36% YoY), and the FY2024 full-year result was -$10.9 million, down 644.87% from the prior year.
- Gains from Investment Securities fell to -$5.8 million in Q3 2024, from -$4.5 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.4 million in Q2 2023 to a low of -$5.8 million in Q3 2024.
- A 4-year average of -$997500.0 and a median of $79000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Peak annual rise in Gains from Investment Securities reached 1708.86% in 2023, while the deepest fall reached 5150.63% in 2023.
- Tracing BNGO's Gains from Investment Securities over 4 years: stood at $66000.0 in 2021, then grew by 19.7% to $79000.0 in 2022, then tumbled by 5150.63% to -$4.0 million in 2023, then plunged by 44.71% to -$5.8 million in 2024.
- Business Quant data shows BNGO's Gains from Investment Securities at -$5.8 million in Q3 2024, -$4.5 million in Q2 2024, and -$640000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Bionano Genomics | 11.87 Mn | -1.82 Mn | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -5.77 Mn |
| Sep 30, 2024 | -5.77 Mn |
| Jun 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -4.48 Mn |
| Mar 31, 2024 | -640,000.00 |
| Mar 31, 2024 | -640,000.00 |
| Dec 31, 2023 | -3.99 Mn |
| Dec 31, 2023 | -3.99 Mn |
| Sep 30, 2023 | 310,000.00 |
| Sep 30, 2023 | 310,000.00 |
| Jun 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 789,000.00 |
| Mar 31, 2023 | 789,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 79,000.00 |
| Sep 30, 2022 | 79,000.00 |
| Jun 30, 2022 | 79,000.00 |
| Jun 30, 2022 | 79,000.00 |